An article in this morning’s Toronto Star by Tanya Talaga revealed that the Ontario government will begin to fund the smoking cessation drugs Zyban and Champix, as of August 4. This could cost between 10 and 15 million dollars a year, but is likely to result in great savings to the provincial health care system. [...]

Canadian Family Physician | Vol 57: JUNE: Smoking Cessation and neuropsychiatric adverse effects. This article details the numerous psychiatric adverse effects patients can get when attempting smoking cessation and the importance of psychotherapy. Clinical practice guidelines recommend that every patient willing to quit should be offered counselling and pharamacotherapy, unless contraindicated. Reports of neuropsychiatric adverse [...]